摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Alpha-甲基-DL-色氨酸甲酯 | 114524-80-0

中文名称
Alpha-甲基-DL-色氨酸甲酯
中文别名
2-氨基-3-(1H-吲哚-3-基)-2-甲基丙酸甲酯;Α-甲基-DL-色氨酸甲酯;甲基二氨基-3-(氢-吲哚-3基)-2-甲基羧酸
英文名称
methyl 2-(indol-3-ylmethyl)-2-aminopropionate
英文别名
DL-α-methyltryptophan methyl ester;α-methyltryptophan methyl ester;2-amino-3-(1H-indol-3-yl)-2-methyl-propionic acid methyl ester;methyl 2-amino-3-(1H-indol-3-yl)-2-methylpropanoate
Alpha-甲基-DL-色氨酸甲酯化学式
CAS
114524-80-0
化学式
C13H16N2O2
mdl
——
分子量
232.282
InChiKey
RCUNGDZWHFRBBP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    139-142
  • 沸点:
    394.3±27.0 °C(Predicted)
  • 密度:
    1.213±0.06 g/cm3(Predicted)
  • 溶解度:
    可溶于氯仿、DMSO、甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    68.1
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    C
  • 安全说明:
    S26,S36/37/39,S45
  • 危险类别码:
    R34

SDS

SDS:6e0f17fb833324af0cc6882b6b548e2e
查看
Name: Methyl 2-amino-3-(1h-indol-3-yl)-2-methylpropanoate 97% Material Safety Data Sheet
Synonym: Methyl 2-amino-3-(1H-indol-3-yl)-2-methylpropionat
CAS: 114524-80-0
Section 1 - Chemical Product MSDS Name:Methyl 2-amino-3-(1h-indol-3-yl)-2-methylpropanoate 97% Material Safety Data Sheet
Synonym:Methyl 2-amino-3-(1H-indol-3-yl)-2-methylpropionat

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
114524-80-0 Methyl 2-amino-3-(1H-indol-3-yl)-2-met 97% unlisted
Hazard Symbols: C
Risk Phrases: 34

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately. Wash mouth out with water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 114524-80-0: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: tan
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 139 - 142 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C13H16N2O2
Molecular Weight: 232

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, acids, acid chlorides.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, acrid smoke and fumes, ammonia.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 114524-80-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Methyl 2-amino-3-(1H-indol-3-yl)-2-methylpropanoate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.*
Hazard Class: 8
UN Number: 3259
Packing Group: III
IMO
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 3259
Packing Group: III
RID/ADR
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 3259
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 114524-80-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 114524-80-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 114524-80-0 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Rationally designed "dipeptoid" analogs of CCK. .alpha.-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties
    作者:David C. Horwell、John Hughes、John C. Hunter、Martyn C. Pritchard、Reginald S. Richardson、Edward Roberts、Geoffrey N. Woodruff
    DOI:10.1021/jm00105a062
    日期:1991.1
    This paper describes the synthesis and structure-activity relationships (SAR) leading to the first rational design of "dipeptoid" analogues of the neuropeptide cholecystokinin (CCK). Compounds [R-(R*,S*)]-4-[2-[3-(1H-indol-3-yl)-2-methyl-1-oxo-2-[(tricyclo [3.3.1.1(3,7)]dec-2-yloxy)carbonyl]amino]propyl]amino]-3- phenylpropyl]-amino]-4-oxo-2-butenoic acid, [R-(R*,R*)]-4-[2-[3-(1H-indol-3-yl)-2-met
    本文介绍了合成和结构-活性关系(SAR),从而导致了神经肽胆囊收缩素(CCK)的“二肽”类似物的第一个合理设计。化合物[R-(R *,S *)]-4- [2- [3-(1H-吲哚-3-基)-2-甲基-1-氧代-2-[(三环[3.3.1.1(3 ,7)]癸-2-基氧基)羰基]基]丙基]基] -3-苯基丙基]-基] -4-氧代-2-丁烯酸,[R-(R *,R *)]-4- [2- [3-(1H-吲哚-3-基)-2-甲基-1-氧-2-([三环[3.3.1.1(3,7)]癸-2-氧)羰基]基]丙基]基] -1-苯乙基]基] -4-氧代-2-丁烯酸和[R-(R *,R *)]-4- [2- [3-(1H-吲哚-3-基) -2-甲基-1-氧代-2-[((三环[3.3.1.1(3,7)]癸-2-基氧基)羰基]基]丙基]基] -1-苯基乙基]基] -4-氧代丁酸(29d)的CCK-B结合亲和力IC50
  • 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl]
    申请人:Warner-Lambert Company
    公开号:US04757151A1
    公开(公告)日:1988-07-12
    Certain 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl]propanamides demonstrate activity as appetite suppressants. The compounds, pharmaceutical compositions, and a method of suppressing appetite are disclosed.
    某些2-取代-[2-取代基]-N-芳基烷基-3-[吲哚-3-基]丙酰胺表现出作为食欲抑制剂的活性。该化合物、药物组合物和抑制食欲的方法已被披露。
  • Alpha-alkyl substituted N-acyltryptophanols
    申请人:Bayer Schering Pharma Aktiengesellschaft
    公开号:EP2025669A1
    公开(公告)日:2009-02-18
    The present invention relates to α-alkyl substituted N-acyltryptophanols of the formula I in which R1, R2, R3, R4, R5, R6, Q, X and W have the meaning as defined in the description. The compounds according to the invention are effective FSH antagonists and can be used for example for fertility control in men or in women, or for the prevention and/or treatment of osteoporosis.
    本发明涉及式I的α-烷基取代的N-酰基色酸醇,其中R1、R2、R3、R4、R5、R6、Q、X和W的含义如描述中所定义。本发明的化合物是有效的FSH拮抗剂,例如可用于男性或女性的生育控制,或用于骨质疏松的预防和/或治疗。
  • [EN] BENZOTHIENOPYRIDINES FOR USE AS INHIBITORS OF EG5 KINESIN<br/>[FR] BENZOTHIENOPYRIDINES DESTINEES A ETRE UTILISEES EN TANT QU'INHIBITEURS DE LA KINESINE EG5
    申请人:ALTANA PHARMA AG
    公开号:WO2006018435A1
    公开(公告)日:2006-02-23
    Compounds of a certain formula I, in which R1, R2, R3, R4 and X have the meanings indicated in the description, are novel effective compounds with Eg5 inhibitory, anti-proliferative and/or apoptosis inducing activity.
    具有特定化学式I的化合物,其中R1、R2、R3、R4和X具有描述中指示的含义,是具有Eg5抑制、抗增殖和/或诱导凋亡活性的新型有效化合物。
  • Process for the preparation of alpha-dimethylaminomethyl-tryptophan methyl ester
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP1127875A1
    公开(公告)日:2001-08-29
    The invention is concerned with a process for the preparation of α-dimethylaminomethyltryptophan methyl ester, wherein (S)-2-benzylidene-amino)-3-(1H-indol-3-yl)-propionic acid methyl ester is reacted with 1-dimethylaminomethylbenzotriazole to give racemic α-dimethylaminomethyltryptophan methyl ester.
    本发明涉及一种制备α-二甲氨基甲基色氨酸甲酯的过程,其中反应(S)-2-苯甲醛基)-3-(1H-吲哚-3-基)-丙酸甲酯和1-二甲氨基甲基苯并三唑,以得到外消旋的α-二甲氨基甲基色氨酸甲酯。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸